APO Research
Talk to an analyst

APO RESEARCH · REPORT

Chronic Low Back Pain Drug

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Chronic Low Back Pain Drug Industry Growth and Trends Forecast to 2032

22 December 2025102 pages

Choose your research edition.

Industry ResearchChronic Low Back Pain Drug Industry Research Report 2026125 pages · $2,950 USDIndustry Growth & TrendsGlobal Chronic Low Back Pain Drug Industry Growth and Trends Forecast to 2032102 pages · $3,450 USDMarket StructureGlobal Chronic Low Back Pain Drug Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032194 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Chronic Low Back Pain Drug Market Outlook and Growth Opportunities 2026197 pages · $4,250 USDMarket Analysis & ForecastGlobal Chronic Low Back Pain Drug Market Analysis and Forecast 2026-2032195 pages · $4,950 USD

Market perspective

The global Chronic Low Back Pain Drug market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Chronic Low Back Pain Drug is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Chronic Low Back Pain Drug is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Chronic Low Back Pain Drug is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Chronic Low Back Pain Drug include Takeda Pharmaceutical, Teva Pharmaceuticals, Sanofi, Johnson & Johnson, Novartis, Merck & Co., Inc., Mylan, Eli Lilly and Company and Pfizer, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Chronic Low Back Pain Drug market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Chronic Low Back Pain Drug market size, estimates, and forecasts are presented in terms of sales volume (k units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Chronic Low Back Pain Drug market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Chronic Low Back Pain Drug.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Chronic Low Back Pain Drug market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Chronic Low Back Pain Drug Market by Company

Takeda Pharmaceutical

Teva Pharmaceuticals

Sanofi

Johnson & Johnson

Novartis

Merck & Co., Inc.

Mylan

Eli Lilly and Company

Pfizer

Endo Pharmaceuticals Inc

Dr. Reddy's Laboratories Ltd

Allergan

Chronic Low Back Pain Drug Segment by Type

Analgesic medications

Antidepressants

Anticonvulsants

Nonsteroidal anti-inflammatory drugs

Counter irritants

Chronic Low Back Pain Drug Segment by Application

Clinics

Hospitals

Ambulatory Surgical Centers

Others

Chronic Low Back Pain Drug Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Chronic Low Back Pain Drug market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Chronic Low Back Pain Drug and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Chronic Low Back Pain Drug.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Chronic Low Back Pain Drug manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Chronic Low Back Pain Drug in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of Analgesic medications Table 2. Major Company of Antidepressants Table 3. Major Company of Anticonvulsants Table 4. Major Company of Nonsteroidal anti-inflammatory drugs Table 5. Major Company of Counter irritants Table 6. Global Chronic Low Back Pain Drug Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 7. Global Chronic Low Back Pain Drug Sales by Type (2021-2026) & (k units) Table 8. Global Chronic Low Back Pain Drug Sales Market Share in Volume by Type (2021-2026) Table 9. Global Chronic Low Back Pain Drug Sales by Type (2021-2026) & (US$ Million) Table 10. Global Chronic Low Back Pain Drug Sales Market Share in Value by Type (2021-2026) Table 11. Global Chronic Low Back Pain Drug Price by Type (2021-2026) & (US$/unit) Table 12. Global Chronic Low Back Pain Drug Sales by Type (2027-2032) & (k units) Table 13. Global Chronic Low Back Pain Drug Sales Market Share in Volume by Type (2027-2032) Table 14. Global Chronic Low Back Pain Drug Sales by Type (2027-2032) & (US$ Million) Table 15. Global Chronic Low Back Pain Drug Sales Market Share in Value by Type (2027-2032) Table 16. Global Chronic Low Back Pain Drug Price by Type (2027-2032) & (US$/unit) Table 17. North America Chronic Low Back Pain Drug Sales by Type (2021-2026) & (k units) Table 18. North America Chronic Low Back Pain Drug Sales by Type (2021-2026) & (US$ Million) Table 19. Europe Chronic Low Back Pain Drug Sales by Type (2021-2026) & (k units) Table 20. Europe Chronic Low Back Pain Drug Sales by Type (2021-2026) & (US$ Million) Table 21. Asia-Pacific Chronic Low Back Pain Drug Sales by Type (2021-2026) & (k units) Table 22. Asia-Pacific Chronic Low Back Pain Drug Sales by Type (2021-2026) & (US$ Million) Table 23. Latin America Chronic Low Back Pain Drug Sales by Type (2021-2026) & (k units) Table 24. Latin America Chronic Low Back Pain Drug Sales by Type (2021-2026) & (US$ Million) Table 25. Middle East and Africa Chronic Low Back Pain Drug Sales by Type (2021-2026) & (k units) Table 26. Middle East and Africa Chronic Low Back Pain Drug Sales by Type (2021-2026) & (US$ Million) Table 27. Chronic Low Back Pain Drug Industry Trends Table 28. Chronic Low Back Pain Drug Industry Drivers Table 29. Chronic Low Back Pain Drug Industry Opportunities and Challenges Table 30. Chronic Low Back Pain Drug Industry Restraints Table 31. Global Chronic Low Back Pain Drug Sales Revenue by Company (US$ Million) & (2021-2026) Table 32. Global Chronic Low Back Pain Drug Revenue Market Share by Company (2021-2026) Table 33. Global Chronic Low Back Pain Drug Sales by Company (2021-2026) & (k units) Table 34. Global Chronic Low Back Pain Drug Sales Share by Company (2021-2026) Table 35. Global Chronic Low Back Pain Drug Market Price by Company (2021-2026) & (US$/unit) Table 36. Global Chronic Low Back Pain Drug Industry Company Ranking, 2024 VS 2025 VS 2026 Table 37. Global Chronic Low Back Pain Drug Major Company Production Sites and Headquarters Table 38. Global Chronic Low Back Pain Drug Company, Product Type & Application Table 39. Global Chronic Low Back Pain Drug Company Establishment Date Table 40. Global Company Market Concentration Ratio (CR5 and HHI) Table 41. Global Chronic Low Back Pain Drug by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 42. Global Chronic Low Back Pain Drug Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 43. Global Chronic Low Back Pain Drug Sales by Region (2021-2026) & (k units) Table 44. Global Chronic Low Back Pain Drug Sales Market Share in Volume by Region (2021-2026) Table 45. Global Chronic Low Back Pain Drug Sales by Region (2021-2026) & (US$ Million) Table 46. Global Chronic Low Back Pain Drug Sales Market Share in Value by Region (2021-2026) Table 47. Global Chronic Low Back Pain Drug Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 48. Global Chronic Low Back Pain Drug Sales by Region (2027-2032) & (k units) Table 49. Global Chronic Low Back Pain Drug Sales Market Share in Volume by Region (2027-2032) Table 50. Global Chronic Low Back Pain Drug Sales by Region (2027-2032) & (US$ Million) Table 51. Global Chronic Low Back Pain Drug Sales Market Share in Value by Region (2027-2032) Table 52. Global Chronic Low Back Pain Drug Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2027-2032) Table 53. Global Chronic Low Back Pain Drug Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 54. Global Chronic Low Back Pain Drug Sales by Application (2021-2026) & (k units) Table 55. Global Chronic Low Back Pain Drug Sales Market Share in Volume by Application (2021-2026) Table 56. Global Chronic Low Back Pain Drug Sales by Application (2021-2026) & (US$ Million) Table 57. Global Chronic Low Back Pain Drug Sales Market Share in Value by Application (2021-2026) Table 58. Global Chronic Low Back Pain Drug Price by Application (2021-2026) & (US$/unit) Table 59. Global Chronic Low Back Pain Drug Sales by Application (2027-2032) & (k units) Table 60. Global Chronic Low Back Pain Drug Sales Market Share in Volume by Application (2027-2032) Table 61. Global Chronic Low Back Pain Drug Sales by Application (2027-2032) & (US$ Million) Table 62. Global Chronic Low Back Pain Drug Sales Market Share in Value by Application (2027-2032) Table 63. Global Chronic Low Back Pain Drug Price by Application (2027-2032) & (US$/unit) Table 64. North America Chronic Low Back Pain Drug Sales by Application (2021-2026) & (k units) Table 65. North America Chronic Low Back Pain Drug Sales by Application (2021-2026) & (US$ Million) Table 66. Europe Chronic Low Back Pain Drug Sales by Application (2021-2026) & (k units) Table 67. Europe Chronic Low Back Pain Drug Sales by Application (2021-2026) & (US$ Million) Table 68. Asia-Pacific Chronic Low Back Pain Drug Sales by Application (2021-2026) & (k units) Table 69. Asia-Pacific Chronic Low Back Pain Drug Sales by Application (2021-2026) & (US$ Million) Table 70. Latin America Chronic Low Back Pain Drug Sales by Application (2021-2026) & (k units) Table 71. Latin America Chronic Low Back Pain Drug Sales by Application (2021-2026) & (US$ Million) Table 72. Middle East and Africa Chronic Low Back Pain Drug Sales by Application (2021-2026) & (k units) Table 73. Middle East and Africa Chronic Low Back Pain Drug Sales by Application (2021-2026) & (US$ Million) Table 74. Takeda Pharmaceutical Company Information Table 75. Takeda Pharmaceutical Business Overview Table 76. Takeda Pharmaceutical Chronic Low Back Pain Drug Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 77. Takeda Pharmaceutical Chronic Low Back Pain Drug Product Portfolio Table 78. Takeda Pharmaceutical Recent Development Table 79. Teva Pharmaceuticals Company Information Table 80. Teva Pharmaceuticals Business Overview Table 81. Teva Pharmaceuticals Chronic Low Back Pain Drug Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 82. Teva Pharmaceuticals Chronic Low Back Pain Drug Product Portfolio Table 83. Teva Pharmaceuticals Recent Development Table 84. Sanofi Company Information Table 85. Sanofi Business Overview Table 86. Sanofi Chronic Low Back Pain Drug Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 87. Sanofi Chronic Low Back Pain Drug Product Portfolio Table 88. Sanofi Recent Development Table 89. Johnson & Johnson Company Information Table 90. Johnson & Johnson Business Overview Table 91. Johnson & Johnson Chronic Low Back Pain Drug Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 92. Johnson & Johnson Chronic Low Back Pain Drug Product Portfolio Table 93. Johnson & Johnson Recent Development Table 94. Novartis Company Information Table 95. Novartis Business Overview Table 96. Novartis Chronic Low Back Pain Drug Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 97. Novartis Chronic Low Back Pain Drug Product Portfolio Table 98. Novartis Recent Development Table 99. Merck & Co., Inc. Company Information Table 100. Merck & Co., Inc. Business Overview Table 101. Merck & Co., Inc. Chronic Low Back Pain Drug Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 102. Merck & Co., Inc. Chronic Low Back Pain Drug Product Portfolio Table 103. Merck & Co., Inc. Recent Development Table 104. Mylan Company Information Table 105. Mylan Business Overview Table 106. Mylan Chronic Low Back Pain Drug Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 107. Mylan Chronic Low Back Pain Drug Product Portfolio Table 108. Mylan Recent Development Table 109. Eli Lilly and Company Company Information Table 110. Eli Lilly and Company Business Overview Table 111. Eli Lilly and Company Chronic Low Back Pain Drug Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 112. Eli Lilly and Company Chronic Low Back Pain Drug Product Portfolio Table 113. Eli Lilly and Company Recent Development Table 114. Pfizer Company Information Table 115. Pfizer Business Overview Table 116. Pfizer Chronic Low Back Pain Drug Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 117. Pfizer Chronic Low Back Pain Drug Product Portfolio Table 118. Pfizer Recent Development Table 119. Endo Pharmaceuticals Inc Company Information Table 120. Endo Pharmaceuticals Inc Business Overview Table 121. Endo Pharmaceuticals Inc Chronic Low Back Pain Drug Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 122. Endo Pharmaceuticals Inc Chronic Low Back Pain Drug Product Portfolio Table 123. Endo Pharmaceuticals Inc Recent Development Table 124. Dr. Reddy's Laboratories Ltd Company Information Table 125. Dr. Reddy's Laboratories Ltd Business Overview Table 126. Dr. Reddy's Laboratories Ltd Chronic Low Back Pain Drug Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 127. Dr. Reddy's Laboratories Ltd Chronic Low Back Pain Drug Product Portfolio Table 128. Dr. Reddy's Laboratories Ltd Recent Development Table 129. Allergan Company Information Table 130. Allergan Business Overview Table 131. Allergan Chronic Low Back Pain Drug Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 132. Allergan Chronic Low Back Pain Drug Product Portfolio Table 133. Allergan Recent Development Table 134. North America Chronic Low Back Pain Drug Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 135. North America Chronic Low Back Pain Drug Sales by Country (2021-2026) & (k units) Table 136. North America Chronic Low Back Pain Drug Sales Market Share by Country (2021-2026) Table 137. North America Chronic Low Back Pain Drug Sales Forecast by Country (2027-2032) & (k units) Table 138. North America Chronic Low Back Pain Drug Sales Market Share Forecast by Country (2027-2032) Table 139. North America Chronic Low Back Pain Drug Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 140. North America Chronic Low Back Pain Drug Market Size by Country (2021-2026) & (US$ Million) Table 141. North America Chronic Low Back Pain Drug Market Share by Country (2021-2026) Table 142. North America Chronic Low Back Pain Drug Market Size Forecast by Country (2027-2032) & (US$ Million) Table 143. North America Chronic Low Back Pain Drug Market Share Forecast by Country (2027-2032) Table 144. Europe Chronic Low Back Pain Drug Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 145. Europe Chronic Low Back Pain Drug Sales by Country (2021-2026) & (k units) Table 146. Europe Chronic Low Back Pain Drug Sales Market Share by Country (2021-2026) Table 147. Europe Chronic Low Back Pain Drug Sales Forecast by Country (2027-2032) & (k units) Table 148. Europe Chronic Low Back Pain Drug Sales Market Share Forecast by Country (2027-2032) Table 149. Europe Chronic Low Back Pain Drug Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 150. Europe Chronic Low Back Pain Drug Market Size by Country (2021-2026) & (US$ Million) Table 151. Europe Chronic Low Back Pain Drug Market Share by Country (2021-2026) Table 152. Europe Chronic Low Back Pain Drug Market Size Forecast by Country (2027-2032) & (US$ Million) Table 153. Europe Chronic Low Back Pain Drug Market Share Forecast by Country (2027-2032) Table 154. Asia-Pacific Chronic Low Back Pain Drug Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 155. Asia-Pacific Chronic Low Back Pain Drug Sales by Country (2021-2026) & (k units) Table 156. Asia-Pacific Chronic Low Back Pain Drug Sales Market Share by Country (2021-2026) Table 157. Asia-Pacific Chronic Low Back Pain Drug Sales Forecast by Country (2027-2032) & (k units) Table 158. Asia-Pacific Chronic Low Back Pain Drug Sales Market Share Forecast by Country (2027-2032) Table 159. Asia-Pacific Chronic Low Back Pain Drug Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 160. Asia-Pacific Chronic Low Back Pain Drug Market Size by Country (2021-2026) & (US$ Million) Table 161. Asia-Pacific Chronic Low Back Pain Drug Market Share by Country (2021-2026) Table 162. Asia-Pacific Chronic Low Back Pain Drug Market Size Forecast by Country (2027-2032) & (US$ Million) Table 163. Asia-Pacific Chronic Low Back Pain Drug Market Share Forecast by Country (2027-2032) Table 164. Latin America Chronic Low Back Pain Drug Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 165. Latin America Chronic Low Back Pain Drug Sales by Country (2021-2026) & (k units) Table 166. Latin America Chronic Low Back Pain Drug Sales Market Share by Country (2021-2026) Table 167. Latin America Chronic Low Back Pain Drug Sales Forecast by Country (2027-2032) & (k units) Table 168. Latin America Chronic Low Back Pain Drug Sales Market Share Forecast by Country (2027-2032) Table 169. Latin America Chronic Low Back Pain Drug Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 170. Latin America Chronic Low Back Pain Drug Market Size by Country (2021-2026) & (US$ Million) Table 171. Latin America Chronic Low Back Pain Drug Market Share by Country (2021-2026) Table 172. Latin America Chronic Low Back Pain Drug Market Size Forecast by Country (2027-2032) & (US$ Million) Table 173. Latin America Chronic Low Back Pain Drug Market Share Forecast by Country (2027-2032) Table 174. Middle East and Africa Chronic Low Back Pain Drug Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 175. Middle East and Africa Chronic Low Back Pain Drug Sales by Country (2021-2026) & (k units) Table 176. Middle East and Africa Chronic Low Back Pain Drug Sales Market Share by Country (2021-2026) Table 177. Middle East and Africa Chronic Low Back Pain Drug Sales Forecast by Country (2027-2032) & (k units) Table 178. Middle East and Africa Chronic Low Back Pain Drug Sales Market Share Forecast by Country (2027-2032) Table 179. Middle East and Africa Chronic Low Back Pain Drug Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 180. Middle East and Africa Chronic Low Back Pain Drug Market Size by Country (2021-2026) & (US$ Million) Table 181. Middle East and Africa Chronic Low Back Pain Drug Market Share by Country (2021-2026) Table 182. Middle East and Africa Chronic Low Back Pain Drug Market Size Forecast by Country (2027-2032) & (US$ Million) Table 183. Middle East and Africa Chronic Low Back Pain Drug Market Share Forecast by Country (2027-2032) Table 184. Key Raw Materials Table 185. Raw Materials Key Suppliers Table 186. Chronic Low Back Pain Drug Distributors List Table 187. Chronic Low Back Pain Drug Customers List Table 188. Research Programs/Design for This Report Table 189. Authors List of This Report Table 190. Secondary Sources Table 191. Primary Sources List of Figures Figure 1. Chronic Low Back Pain Drug Image Figure 2. Global Chronic Low Back Pain Drug Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Chronic Low Back Pain Drug Market Size (2021-2032) & (US$ Million) Figure 4. Global Chronic Low Back Pain Drug Sales (2021-2032) & (k units) Figure 5. Analgesic medications Image Figure 6. Global Analgesic medications Sales YoY Growth (2021-2032) & (k units) Figure 7. Antidepressants Image Figure 8. Global Antidepressants Sales YoY Growth (2021-2032) & (k units) Figure 9. Anticonvulsants Image Figure 10. Global Anticonvulsants Sales YoY Growth (2021-2032) & (k units) Figure 11. Nonsteroidal anti-inflammatory drugs Image Figure 12. Global Nonsteroidal anti-inflammatory drugs Sales YoY Growth (2021-2032) & (k units) Figure 13. Counter irritants Image Figure 14. Global Counter irritants Sales YoY Growth (2021-2032) & (k units) Figure 15. Global Chronic Low Back Pain Drug Market Size Overview by Type (2021-2032) & (US$ Million) Figure 16. Global Chronic Low Back Pain Drug Market Share by Type 2025 VS 2032 Figure 17. North America Chronic Low Back Pain Drug Sales Market Share in Volume by Type in 2025 Figure 18. North America Chronic Low Back Pain Drug Sales Market Share in Value by Type in 2025 Figure 19. Europe Chronic Low Back Pain Drug Sales Market Share in Volume by Type in 2025 Figure 20. Europe Chronic Low Back Pain Drug Sales Market Share in Value by Type in 2025 Figure 21. Asia-Pacific Chronic Low Back Pain Drug Sales Market Share in Volume by Type in 2025 Figure 22. Asia-Pacific Chronic Low Back Pain Drug Sales Market Share in Value by Type in 2025 Figure 23. Latin America Chronic Low Back Pain Drug Sales Market Share in Volume by Type in 2025 Figure 24. Latin America Chronic Low Back Pain Drug Sales Market Share in Value by Type in 2025 Figure 25. Middle East and Africa Chronic Low Back Pain Drug Sales Market Share in Volume by Type in 2025 Figure 26. Middle East and Africa Chronic Low Back Pain Drug Sales Market Share in Value by Type in 2025 Figure 27. Global Top 5 and 10 Chronic Low Back Pain Drug Players Market Share by Revenue in 2025 Figure 28. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 29. Clinics Image Figure 30. Global Clinics Sales YoY Growth (2021-2032) & (k units) Figure 31. Hospitals Image Figure 32. Global Hospitals Sales YoY Growth (2021-2032) & (k units) Figure 33. Ambulatory Surgical Centers Image Figure 34. Global Ambulatory Surgical Centers Sales YoY Growth (2021-2032) & (k units) Figure 35. Others Image Figure 36. Global Others Sales YoY Growth (2021-2032) & (k units) Figure 37. Global Chronic Low Back Pain Drug Market Size Overview by Application (2021-2032) & (US$ Million) Figure 38. Global Chronic Low Back Pain Drug Market Share by Application 2025 VS 2032 Figure 39. North America Chronic Low Back Pain Drug Sales Market Share in Volume by Application in 2025 Figure 40. North America Chronic Low Back Pain Drug Sales Market Share in Value by Application in 2025 Figure 41. Europe Chronic Low Back Pain Drug Sales Market Share in Volume by Application in 2025 Figure 42. Europe Chronic Low Back Pain Drug Sales Market Share in Value by Application in 2025 Figure 43. Asia-Pacific Chronic Low Back Pain Drug Sales Market Share in Volume by Application in 2025 Figure 44. Asia-Pacific Chronic Low Back Pain Drug Sales Market Share in Value by Application in 2025 Figure 45. Latin America Chronic Low Back Pain Drug Sales Market Share in Volume by Application in 2025 Figure 46. Latin America Chronic Low Back Pain Drug Sales Market Share in Value by Application in 2025 Figure 47. Middle East and Africa Chronic Low Back Pain Drug Sales Market Share in Volume by Application in 2025 Figure 48. Middle East and Africa Chronic Low Back Pain Drug Sales Market Share in Value by Application in 2025 Figure 49. North America Chronic Low Back Pain Drug Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 50. North America Chronic Low Back Pain Drug Sales Share by Country: 2021 VS 2025 VS 2032 Figure 51. North America Chronic Low Back Pain Drug Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 52. North America Chronic Low Back Pain Drug Market Share by Country: 2021 VS 2025 VS 2032 Figure 53. Europe Chronic Low Back Pain Drug Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 54. Europe Chronic Low Back Pain Drug Sales Share by Country: 2021 VS 2025 VS 2032 Figure 55. Europe Chronic Low Back Pain Drug Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 56. Europe Chronic Low Back Pain Drug Market Share by Country: 2021 VS 2025 VS 2032 Figure 57. Asia-Pacific Chronic Low Back Pain Drug Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 58. Asia-Pacific Chronic Low Back Pain Drug Sales Share by Country: 2021 VS 2025 VS 2032 Figure 59. Asia-Pacific Chronic Low Back Pain Drug Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 60. Asia-Pacific Chronic Low Back Pain Drug Market Share by Country: 2021 VS 2025 VS 2032 Figure 61. Latin America Chronic Low Back Pain Drug Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 62. Latin America Chronic Low Back Pain Drug Sales Share by Country: 2021 VS 2025 VS 2032 Figure 63. Latin America Chronic Low Back Pain Drug Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 64. Latin America Chronic Low Back Pain Drug Market Share by Country: 2021 VS 2025 VS 2032 Figure 65. Middle East and Africa Chronic Low Back Pain Drug Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 66. Middle East and Africa Chronic Low Back Pain Drug Sales Share by Country: 2021 VS 2025 VS 2032 Figure 67. Middle East and Africa Chronic Low Back Pain Drug Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 68. Middle East and Africa Chronic Low Back Pain Drug Market Share by Country: 2021 VS 2025 VS 2032 Figure 69. Chronic Low Back Pain Drug Value Chain Figure 70. Key Raw Materials Price Figure 71. Manufacturing Cost Structure Figure 72. Chronic Low Back Pain Drug Production Mode & Process Figure 73. Direct Comparison with Distribution Share Figure 74. Distributors Profiles Figure 75. Years Considered Figure 76. Research Process Figure 77. Key Executives Interviewed

Scope & coverage.

Types
  • Analgesic medications
  • Antidepressants
  • Anticonvulsants
  • Nonsteroidal anti-inflammatory drugs
  • Counter irritants
Applications
  • Clinics
  • Hospitals
  • Ambulatory Surgical Centers
  • Others
Companies covered
  • Takeda Pharmaceutical
  • Teva Pharmaceuticals
  • Sanofi
  • Johnson & Johnson
  • Novartis
  • Merck & Co., Inc.
  • Mylan
  • Eli Lilly and Company
  • Pfizer
  • Endo Pharmaceuticals Inc
  • Dr. Reddy's Laboratories Ltd
  • Allergan

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Chronic Low Back Pain Drug Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Chronic Low Back Pain Drug Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Chronic Low Back Pain Drug Market by Type
  6. 1.3.1 Analgesic medications
  7. 1.3.2 Antidepressants
  8. 1.3.3 Anticonvulsants
  9. 1.3.4 Nonsteroidal anti-inflammatory drugs
  10. 1.3.5 Counter irritants
  11. 1.4 Global Chronic Low Back Pain Drug Market Size by Type
  12. 1.4.1 Global Chronic Low Back Pain Drug Market Size Overview by Type (2021-2032)
  13. 1.4.2 Global Chronic Low Back Pain Drug Historic Market Size Review by Type (2021-2026)
  14. 1.4.3 Global Chronic Low Back Pain Drug Forecasted Market Size by Type (2027-2032)
  15. 1.5 Key Regions Market Size by Type
  16. 1.5.1 North America Chronic Low Back Pain Drug Sales Breakdown by Type (2021-2026)
  17. 1.5.2 Europe Chronic Low Back Pain Drug Sales Breakdown by Type (2021-2026)
  18. 1.5.3 Asia-Pacific Chronic Low Back Pain Drug Sales Breakdown by Type (2021-2026)
  19. 1.5.4 South America Chronic Low Back Pain Drug Sales Breakdown by Type (2021-2026)
  20. 1.5.5 Middle East and Africa Chronic Low Back Pain Drug Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Chronic Low Back Pain Drug Industry Trends
  2. 2.2 Chronic Low Back Pain Drug Industry Drivers
  3. 2.3 Chronic Low Back Pain Drug Industry Opportunities and Challenges
  4. 2.4 Chronic Low Back Pain Drug Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Chronic Low Back Pain Drug Revenue (2021-2026)
  2. 3.2 Global Top Players by Chronic Low Back Pain Drug Sales (2021-2026)
  3. 3.3 Global Top Players by Chronic Low Back Pain Drug Price (2021-2026)
  4. 3.4 Global Chronic Low Back Pain Drug Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Chronic Low Back Pain Drug Major Company Production Sites & Headquarters
  6. 3.6 Global Chronic Low Back Pain Drug Company, Product Type & Application
  7. 3.7 Global Chronic Low Back Pain Drug Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Chronic Low Back Pain Drug Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Chronic Low Back Pain Drug Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Chronic Low Back Pain Drug Tier 1, Tier 2, and Tier 3
4 Chronic Low Back Pain Drug Regional Status and Outlook
  1. 4.1 Global Chronic Low Back Pain Drug Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Chronic Low Back Pain Drug Historic Market Size by Region
  3. 4.2.1 Global Chronic Low Back Pain Drug Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Chronic Low Back Pain Drug Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Chronic Low Back Pain Drug Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Chronic Low Back Pain Drug Forecasted Market Size by Region
  7. 4.3.1 Global Chronic Low Back Pain Drug Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Chronic Low Back Pain Drug Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Chronic Low Back Pain Drug Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Chronic Low Back Pain Drug by Application
  1. 5.1 Chronic Low Back Pain Drug Market by Application
  2. 5.1.1 Clinics
  3. 5.1.2 Hospitals
  4. 5.1.3 Ambulatory Surgical Centers
  5. 5.1.4 Others
  6. 5.2 Global Chronic Low Back Pain Drug Market Size by Application
  7. 5.2.1 Global Chronic Low Back Pain Drug Market Size Overview by Application (2021-2032)
  8. 5.2.2 Global Chronic Low Back Pain Drug Historic Market Size Review by Application (2021-2026)
  9. 5.2.3 Global Chronic Low Back Pain Drug Forecasted Market Size by Application (2027-2032)
  10. 5.3 Key Regions Market Size by Application
  11. 5.3.1 North America Chronic Low Back Pain Drug Sales Breakdown by Application (2021-2026)
  12. 5.3.2 Europe Chronic Low Back Pain Drug Sales Breakdown by Application (2021-2026)
  13. 5.3.3 Asia-Pacific Chronic Low Back Pain Drug Sales Breakdown by Application (2021-2026)
  14. 5.3.4 South America Chronic Low Back Pain Drug Sales Breakdown by Application (2021-2026)
  15. 5.3.5 Middle East and Africa Chronic Low Back Pain Drug Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Takeda Pharmaceutical
  2. 6.1.1 Takeda Pharmaceutical Company Information
  3. 6.1.2 Takeda Pharmaceutical Business Overview
  4. 6.1.3 Takeda Pharmaceutical Chronic Low Back Pain Drug Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Takeda Pharmaceutical Chronic Low Back Pain Drug Product Portfolio
  6. 6.1.5 Takeda Pharmaceutical Recent Developments
  7. 6.2 Teva Pharmaceuticals
  8. 6.2.1 Teva Pharmaceuticals Company Information
  9. 6.2.2 Teva Pharmaceuticals Business Overview
  10. 6.2.3 Teva Pharmaceuticals Chronic Low Back Pain Drug Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Teva Pharmaceuticals Chronic Low Back Pain Drug Product Portfolio
  12. 6.2.5 Teva Pharmaceuticals Recent Developments
  13. 6.3 Sanofi
  14. 6.3.1 Sanofi Company Information
  15. 6.3.2 Sanofi Business Overview
  16. 6.3.3 Sanofi Chronic Low Back Pain Drug Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Sanofi Chronic Low Back Pain Drug Product Portfolio
  18. 6.3.5 Sanofi Recent Developments
  19. 6.4 Johnson & Johnson
  20. 6.4.1 Johnson & Johnson Company Information
  21. 6.4.2 Johnson & Johnson Business Overview
  22. 6.4.3 Johnson & Johnson Chronic Low Back Pain Drug Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 Johnson & Johnson Chronic Low Back Pain Drug Product Portfolio
  24. 6.4.5 Johnson & Johnson Recent Developments
  25. 6.5 Novartis
  26. 6.5.1 Novartis Company Information
  27. 6.5.2 Novartis Business Overview
  28. 6.5.3 Novartis Chronic Low Back Pain Drug Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 Novartis Chronic Low Back Pain Drug Product Portfolio
  30. 6.5.5 Novartis Recent Developments
  31. 6.6 Merck & Co., Inc.
  32. 6.6.1 Merck & Co., Inc. Company Information
  33. 6.6.2 Merck & Co., Inc. Business Overview
  34. 6.6.3 Merck & Co., Inc. Chronic Low Back Pain Drug Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 Merck & Co., Inc. Chronic Low Back Pain Drug Product Portfolio
  36. 6.6.5 Merck & Co., Inc. Recent Developments
  37. 6.7 Mylan
  38. 6.7.1 Mylan Company Information
  39. 6.7.2 Mylan Business Overview
  40. 6.7.3 Mylan Chronic Low Back Pain Drug Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 Mylan Chronic Low Back Pain Drug Product Portfolio
  42. 6.7.5 Mylan Recent Developments
  43. 6.8 Eli Lilly and Company
  44. 6.8.1 Eli Lilly and Company Company Information
  45. 6.8.2 Eli Lilly and Company Business Overview
  46. 6.8.3 Eli Lilly and Company Chronic Low Back Pain Drug Sales, Revenue and Gross Margin (2021-2026)
  47. 6.8.4 Eli Lilly and Company Chronic Low Back Pain Drug Product Portfolio
  48. 6.8.5 Eli Lilly and Company Recent Developments
  49. 6.9 Pfizer
  50. 6.9.1 Pfizer Company Information
  51. 6.9.2 Pfizer Business Overview
  52. 6.9.3 Pfizer Chronic Low Back Pain Drug Sales, Revenue and Gross Margin (2021-2026)
  53. 6.9.4 Pfizer Chronic Low Back Pain Drug Product Portfolio
  54. 6.9.5 Pfizer Recent Developments
  55. 6.10 Endo Pharmaceuticals Inc
  56. 6.10.1 Endo Pharmaceuticals Inc Company Information
  57. 6.10.2 Endo Pharmaceuticals Inc Business Overview
  58. 6.10.3 Endo Pharmaceuticals Inc Chronic Low Back Pain Drug Sales, Revenue and Gross Margin (2021-2026)
  59. 6.10.4 Endo Pharmaceuticals Inc Chronic Low Back Pain Drug Product Portfolio
  60. 6.10.5 Endo Pharmaceuticals Inc Recent Developments
  61. 6.11 Dr. Reddy's Laboratories Ltd
  62. 6.11.1 Dr. Reddy's Laboratories Ltd Company Information
  63. 6.11.2 Dr. Reddy's Laboratories Ltd Business Overview
  64. 6.11.3 Dr. Reddy's Laboratories Ltd Chronic Low Back Pain Drug Sales, Revenue and Gross Margin (2021-2026)
  65. 6.11.4 Dr. Reddy's Laboratories Ltd Chronic Low Back Pain Drug Product Portfolio
  66. 6.11.5 Dr. Reddy's Laboratories Ltd Recent Developments
  67. 6.12 Allergan
  68. 6.12.1 Allergan Company Information
  69. 6.12.2 Allergan Business Overview
  70. 6.12.3 Allergan Chronic Low Back Pain Drug Sales, Revenue and Gross Margin (2021-2026)
  71. 6.12.4 Allergan Chronic Low Back Pain Drug Product Portfolio
  72. 6.12.5 Allergan Recent Developments
7 North America by Country
  1. 7.1 North America Chronic Low Back Pain Drug Sales by Country
  2. 7.1.1 North America Chronic Low Back Pain Drug Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Chronic Low Back Pain Drug Sales by Country (2021-2026)
  4. 7.1.3 North America Chronic Low Back Pain Drug Sales Forecast by Country (2027-2032)
  5. 7.2 North America Chronic Low Back Pain Drug Market Size by Country
  6. 7.2.1 North America Chronic Low Back Pain Drug Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Chronic Low Back Pain Drug Market Size by Country (2021-2026)
  8. 7.2.3 North America Chronic Low Back Pain Drug Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Chronic Low Back Pain Drug Sales by Country
  2. 8.1.1 Europe Chronic Low Back Pain Drug Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Chronic Low Back Pain Drug Sales by Country (2021-2026)
  4. 8.1.3 Europe Chronic Low Back Pain Drug Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Chronic Low Back Pain Drug Market Size by Country
  6. 8.2.1 Europe Chronic Low Back Pain Drug Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Chronic Low Back Pain Drug Market Size by Country (2021-2026)
  8. 8.2.3 Europe Chronic Low Back Pain Drug Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Chronic Low Back Pain Drug Sales by Country
  2. 9.1.1 Asia-Pacific Chronic Low Back Pain Drug Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Chronic Low Back Pain Drug Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Chronic Low Back Pain Drug Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Chronic Low Back Pain Drug Market Size by Country
  6. 9.2.1 Asia-Pacific Chronic Low Back Pain Drug Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Chronic Low Back Pain Drug Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Chronic Low Back Pain Drug Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Chronic Low Back Pain Drug Sales by Country
  2. 10.1.1 South America Chronic Low Back Pain Drug Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Chronic Low Back Pain Drug Sales by Country (2021-2026)
  4. 10.1.3 South America Chronic Low Back Pain Drug Sales Forecast by Country (2027-2032)
  5. 10.2 South America Chronic Low Back Pain Drug Market Size by Country
  6. 10.2.1 South America Chronic Low Back Pain Drug Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Chronic Low Back Pain Drug Market Size by Country (2021-2026)
  8. 10.2.3 South America Chronic Low Back Pain Drug Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Chronic Low Back Pain Drug Sales by Country
  2. 11.1.1 Middle East and Africa Chronic Low Back Pain Drug Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Chronic Low Back Pain Drug Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Chronic Low Back Pain Drug Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Chronic Low Back Pain Drug Market Size by Country
  6. 11.2.1 Middle East and Africa Chronic Low Back Pain Drug Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Chronic Low Back Pain Drug Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Chronic Low Back Pain Drug Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Chronic Low Back Pain Drug Value Chain Analysis
  2. 12.1.1 Chronic Low Back Pain Drug Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Chronic Low Back Pain Drug Production Mode & Process
  7. 12.2 Chronic Low Back Pain Drug Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Chronic Low Back Pain Drug Distributors
  10. 12.2.3 Chronic Low Back Pain Drug Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst